Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Avil
2. Bimaleate, Pheniramine
3. Daneral
4. Histapyridamine
5. Maleate, Pheniramine
6. Pheniramine
7. Pheniramine Bimaleate
8. Propheniramine
9. Prophenpyridamine
1. 132-20-7
2. Inhiston
3. Trimetose
4. Daneral
5. Naphcon A
6. Pheniramine Hydrogen Maleate
7. Pheniramine Maleate Salt
8. Prophenpyridamine Maleate
9. Antolozine
10. Fervex
11. Pheniramine (maleate)
12. 1-phenyl-1-(2-pyridyl)-3-dimethylaminopropane Maleate
13. Nsc-757270
14. Chebi:31990
15. Nyw905655b
16. Pm-241
17. Avil-retard
18. N,n-dimethyl-3-phenyl-3-(2-pyridyl)propylamine Hydrogen Maleate
19. 2-pyridinepropanamine, N,n-dimethyl-gamma-phenyl-, (2z)-2-butenedioate (1:1)
20. Pheniramine Maleate [usan]
21. Ccris 6265
22. Sr-01000075263
23. Einecs 205-051-4
24. Ho 11513
25. N,n-dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine Maleate
26. Unii-nyw905655b
27. Pheniramine Maleate [usan:usp]
28. Prestwick_769
29. Mfcd00079250
30. 2-(alpha-(2-(dimethylamino)ethyl)benzyl)pyridine, Maleate
31. 2-(alpha-(2-(dimethylamino)ethyl)benzyl)pyridine, Bimaleate
32. Phenyl(2-pyridyl)(beta-n,n-dimethylaminomethyl) Methane Maleate
33. 1-(n,n-dimethylamino)-3-(phenyl-3-alpha-pyridyl)propane Maleate
34. 2-pyridinepropanamine, N,n-dimethyl-gamma-phenyl-, (z)-2-butenedioate (1:1)
35. Chembl1653
36. Schembl25318
37. Mls001148181
38. Spectrum1500478
39. Pheniramine Maleate (jan/usp)
40. 2-(alpha-(2-dimethylaminoethyl)benzyl)pyridine Bimaleate
41. Pheniramine Maleate [mi]
42. Hms500l17
43. Pheniramine Maleate [jan]
44. (z)-but-2-enedioic Acid;n,n-dimethyl-3-phenyl-3-pyridin-2-ylpropan-1-amine
45. Hms1568k19
46. Hms1920f22
47. Hms2091p04
48. Hms2095k19
49. Hms2232i20
50. Hms3263e03
51. Hms3712k19
52. Hms3885m20
53. Pharmakon1600-01500478
54. Pheniramine Maleate [vandf]
55. Hy-b0971
56. Pheniramine Maleate [mart.]
57. Tox21_500981
58. Ccg-39109
59. Nsc757270
60. Pheniramine Maleate [usp-rs]
61. Pheniramine Maleate [who-dd]
62. Pyridine, 2-(alpha-(2-(dimethylamino)ethyl)benzyl)-, Maleate (1:1)
63. (2z)-but-2-enedioic Acid; Dimethyl[3-phenyl-3-(pyridin-2-yl)propyl]amine
64. Akos026749878
65. Cs-4460
66. Lp00981
67. Nsc 757270
68. 2-pyridinepropanamine, N,n-dimethyl-.gamma.-phenyl-, (2z)-2-butenedioate (1:1)
69. 2-pyridinepropanamine, N,n-dimethyl-.gamma.-phenyl-, (z)-2-butenedioate (1:1)
70. Ncgc00094281-01
71. Ncgc00094281-02
72. Ncgc00094281-03
73. Ncgc00094281-04
74. Ncgc00094281-05
75. Ncgc00261666-01
76. Pheniramine Maleate [ep Impurity]
77. Pheniramine Maleate [orange Book]
78. Ac-15941
79. As-12971
80. Bp166247
81. Pheniramine Maleate [ep Monograph]
82. Smr000653458
83. Pheniramine Maleate [usp Monograph]
84. Eu-0100981
85. P2271
86. S4045
87. Sw196908-3
88. Visine-a Component Pheniramine Maleate
89. Naphcon-a Component Pheniramine Maleate
90. D01174
91. P 6902
92. Pheniramine Maleate Component Of Opcon-a
93. Pheniramine Maleate Component Of Visine-a
94. Pheniramine Maleate Component Of Naphcon-a
95. J-006144
96. Sr-01000075263-1
97. Sr-01000075263-4
98. Sr-01000075263-7
99. Q27114744
100. Benzenepropanoic Acid, 4-(1-methylethyl)-.alpha.-oxo-
101. 1-phenyl-1-(2-pyridyl)-3-dimethaminopropane Maleinate
102. 2-(.alpha.-(2-dimethylaminoethyl)benzyl)pyridine Bimaleate
103. Pheniramine Maleate, European Pharmacopoeia (ep) Reference Standard
104. 2-(.alpha.-(2-(dimethylamino)ethyl)benzyl)pyridine Bimaleate
105. Pheniramine Maleate, United States Pharmacopeia (usp) Reference Standard
106. Pyridine, 2-(.alpha.-(2-(dimethylamino)ethyl)benzyl)-, Maleate (1:1)
107. 155683-11-7
| Molecular Weight | 356.4 g/mol |
|---|---|
| Molecular Formula | C20H24N2O4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 7 |
| Exact Mass | 356.17360725 g/mol |
| Monoisotopic Mass | 356.17360725 g/mol |
| Topological Polar Surface Area | 90.7 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 340 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antipruritics
Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
API SUPPLIERS
DKSH is your trusted partner for companies looking to grow their business in Asia & beyond.
Emay Pharmaceuticals is a GMP-certified API manufacturing company.
Jai Radhe Sales is your partner for all your sourcing needs.
Pharm-Rx is a reputed global importer and distributor of pharmaceutical active ingredients.
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23512
Submission : 2010-01-22
Status : Active
Type : II
Certificate Number : R1-CEP 2015-030 - Rev 00
Issue Date : 2022-03-18
Type : Chemical
Substance Number : 1357
Status : Valid
Date of Issue : 2022-06-29
Valid Till : 2025-07-02
Written Confirmation Number : WC-0218
Address of the Firm :
NDC Package Code : 61281-5000
Start Marketing Date : 2013-11-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
| Available Reg Filing : CN, ASMF |
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
Harika Drugs has been providing a qualitative range of Bulk Drugs/ APIs since 1993.
Date of Issue : 2022-07-27
Valid Till : 2025-07-29
Written Confirmation Number : WC-0179
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-06-19
Pay. Date : 2013-06-07
DMF Number : 8960
Submission : 1991-02-04
Status : Active
Type : II
NDC Package Code : 12294-9994
Start Marketing Date : 1972-06-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35509
Submission : 2022-05-24
Status : Active
Type : II
Date of Issue : 2022-12-09
Valid Till : 2025-07-02
Written Confirmation Number : WC-244
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8538
Submission : 1990-04-26
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION/DROPS;OPHTHALMIC - 0.02675%...DOSAGE - SOLUTION/DROPS;OPHTHALMIC - 0.02675%;0.315%
USFDA APPLICATION NUMBER - 20065
DOSAGE - SOLUTION/DROPS;OPHTHALMIC - 0.025%;0...DOSAGE - SOLUTION/DROPS;OPHTHALMIC - 0.025%;0.3%
USFDA APPLICATION NUMBER - 20485
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Bioplus Life Sciences
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Coating Systems & Additives
Fillers, Diluents & Binders
Controlled & Modified Release
Thickeners and Stabilizers
Solubilizers
Granulation
Topical
Direct Compression
Parenteral
Taste Masking
Lubricants & Glidants
Film Formers & Plasticizers
Rheology Modifiers
Disintegrants & Superdisintegrants
Co-Processed Excipients
Empty Capsules
Emulsifying Agents
Chewable & Orodispersible Aids
Vegetarian Capsules
API Stability Enhancers
Coloring Agents
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
46
PharmaCompass offers a list of Pheniramine Maleate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pheniramine Maleate manufacturer or Pheniramine Maleate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pheniramine Maleate manufacturer or Pheniramine Maleate supplier.
PharmaCompass also assists you with knowing the Pheniramine Maleate API Price utilized in the formulation of products. Pheniramine Maleate API Price is not always fixed or binding as the Pheniramine Maleate Price is obtained through a variety of data sources. The Pheniramine Maleate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pheniramine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pheniramine, including repackagers and relabelers. The FDA regulates Pheniramine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pheniramine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pheniramine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pheniramine supplier is an individual or a company that provides Pheniramine active pharmaceutical ingredient (API) or Pheniramine finished formulations upon request. The Pheniramine suppliers may include Pheniramine API manufacturers, exporters, distributors and traders.
click here to find a list of Pheniramine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pheniramine DMF (Drug Master File) is a document detailing the whole manufacturing process of Pheniramine active pharmaceutical ingredient (API) in detail. Different forms of Pheniramine DMFs exist exist since differing nations have different regulations, such as Pheniramine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pheniramine DMF submitted to regulatory agencies in the US is known as a USDMF. Pheniramine USDMF includes data on Pheniramine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pheniramine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pheniramine suppliers with USDMF on PharmaCompass.
A Pheniramine CEP of the European Pharmacopoeia monograph is often referred to as a Pheniramine Certificate of Suitability (COS). The purpose of a Pheniramine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Pheniramine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Pheniramine to their clients by showing that a Pheniramine CEP has been issued for it. The manufacturer submits a Pheniramine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Pheniramine CEP holder for the record. Additionally, the data presented in the Pheniramine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Pheniramine DMF.
A Pheniramine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Pheniramine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Pheniramine suppliers with CEP (COS) on PharmaCompass.
A Pheniramine written confirmation (Pheniramine WC) is an official document issued by a regulatory agency to a Pheniramine manufacturer, verifying that the manufacturing facility of a Pheniramine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pheniramine APIs or Pheniramine finished pharmaceutical products to another nation, regulatory agencies frequently require a Pheniramine WC (written confirmation) as part of the regulatory process.
click here to find a list of Pheniramine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pheniramine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pheniramine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pheniramine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pheniramine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pheniramine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pheniramine suppliers with NDC on PharmaCompass.
Pheniramine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pheniramine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pheniramine GMP manufacturer or Pheniramine GMP API supplier for your needs.
A Pheniramine CoA (Certificate of Analysis) is a formal document that attests to Pheniramine's compliance with Pheniramine specifications and serves as a tool for batch-level quality control.
Pheniramine CoA mostly includes findings from lab analyses of a specific batch. For each Pheniramine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pheniramine may be tested according to a variety of international standards, such as European Pharmacopoeia (Pheniramine EP), Pheniramine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pheniramine USP).
